Aethlon Medical, Inc. (AEMD) Coverage Initiated by Analysts at HC Wainwright

HC Wainwright started coverage on shares of Aethlon Medical, Inc. (NASDAQ:AEMD) in a research note issued on Monday. The brokerage set a “buy” rating on the medical equipment provider’s stock.

Separately, ValuEngine raised shares of Aethlon Medical from a “strong sell” rating to a “sell” rating in a research note on Friday, September 1st.

Aethlon Medical (AEMD) opened at $0.97 on Monday. Aethlon Medical has a one year low of $0.79 and a one year high of $5.17. The company has a debt-to-equity ratio of 78.00, a quick ratio of 2.97 and a current ratio of 2.97.

Aethlon Medical (NASDAQ:AEMD) last posted its quarterly earnings data on Thursday, November 2nd. The medical equipment provider reported ($0.14) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.16) by $0.02. sell-side analysts expect that Aethlon Medical will post -0.56 earnings per share for the current fiscal year.

WARNING: This article was posted by Sports Perspectives and is the sole property of of Sports Perspectives. If you are accessing this article on another site, it was illegally copied and reposted in violation of US and international copyright legislation. The correct version of this article can be read at

About Aethlon Medical

Aethlon Medical, Inc is a medical device company focused on creating devices for cancer, infectious disease and other life-threatening conditions. The Company operates through two segments: Aethlon, which represents its therapeutic business activities, and ESI, which represents its diagnostic business activities.

Receive News & Ratings for Aethlon Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aethlon Medical Inc. and related companies with's FREE daily email newsletter.

Latest News

Leave a Reply